Research Article
[Retracted] Analysis of Coagulation Abnormality in Patients with Multiple Myeloma and Its Clinical Significance
Table 1
Comparison of general information among groups.
| | Group | Gender | Age (years) | DS staging | | Male | Female | I | II | III |
| | Control group (n = 30) | 18 (60.00%) | 12 (40.00%) | 57.82 ± 6.94 | — | — | — | | Light chain group (n = 24) | 16 (66.67%) | 8 (33.33%) | 56.91 ± 7.05 | 4 (16.67%) | 4 (16.67%) | 16 (66.67%) | | IgG group (n = 36) | 23 (63.89%) | 13 (36.11%) | 58.62 ± 6.51 | 3 (8.33%) | 6 (16.67%) | 27 (75.00%) | | IgA group (n = 20) | 11 (55.00%) | 9 (45.00%) | 58.14 ± 6.73 | 2 (10.00%) | 3 (15.00%) | 15 (75.0%) | | t/χ2 | 0.740 | 0.314 | | 1.112 | | | 0.864 | 0.816 | | 0.892 | |
|
|
